Plain-English translation of NCT01050504 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Researchers are collecting blood and tissue samples from patients with advanced bladder, prostate, or kidney cancer to study the genetic differences between cancers. By analyzing these samples, scientists hope to discover why some patients respond well to treatment while others do not. This knowledge could eventually help doctors predict who will benefit most from specific therapies.
Currently, doctors cannot reliably predict which patients will respond to cancer treatments. This research aims to identify genetic markers that could help match patients with the therapies most likely to work for them, improving treatment outcomes.
You likely qualify if…
You likely don't qualify if…
If you join this study, researchers will collect blood samples and may take small tissue samples either from a biopsy procedure or during surgery you are already having. The study does not involve taking medication or making additional visits beyond what your regular cancer care requires. Your samples will be analyzed in the laboratory to identify genetic patterns related to how cancers respond to treatment.
AI-generated summary from trial data · Jun 30, 2026 · Not medical advice
United States